Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q13907
UPID:
IDI1_HUMAN
Alternative names:
Isopentenyl pyrophosphate isomerase 1
Alternative UPACC:
Q13907; B4E155; Q32Q13; Q53GQ6; Q86U81; Q8WUX8; Q96IZ4; Q9BQ74
Background:
Isopentenyl-diphosphate Delta-isomerase 1, also known as Isopentenyl pyrophosphate isomerase 1, plays a crucial role in the biosynthesis of isoprenoids by catalyzing the conversion of isopentenyl (IPP) to dimethylallyl diphosphate (DMAPP). This enzymatic activity is fundamental for the production of terpenoids, a diverse class of organic compounds with various biological functions.
Therapeutic significance:
Understanding the role of Isopentenyl-diphosphate Delta-isomerase 1 could open doors to potential therapeutic strategies.